Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study
- PMID: 19353239
- PMCID: PMC7102140
- DOI: 10.1007/s12185-009-0285-6
Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study
Abstract
Specific mutations of the TNF-alpha (TNF-alpha) and Lymphotoxin-alpha (LT-alpha) genes are correlated to the outcome of patients during serious infections. This study aimed at correlating these polymorphisms to lethal infections during childhood acute lymphoblastic leukemia (ALL). A matched case-control study of 34 patients who died due to infections during ALL treatment and 68 ALL patients without lethal infections was performed. Genomic DNA was isolated from blood smears and specific fragments including the polymorphic site of each gene were amplified. In the total study population, 23/102 (22.5%) of the children carried at least two variant alleles (high-producer haplotype). The variant genotypes were equally distributed between cases and controls [relative risk (RR) 1.17 (CI 0.33-2.22, P = 0.752)]. With regard to infective organisms, no statistically significant differences could be detected between the groups for bacterial infections [RR 1.59 (CI 0.56-4.50), P 0.379]. Patients with a LT-alpha (10.5 kb/5.5 kb; 5.5 kb/5.5 kb) haplotype, however, seemed to have a significant higher risk of attracting a lethal infection during induction/consolidation chemotherapy (RR 2.98, CI 0.98-9.01, P = 0.05). These results support a role of specific genetic polymorphisms on lethal infections during induction chemotherapy of ALL treatment.
Similar articles
-
Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.J Clin Oncol. 2005 Nov 20;23(33):8414-21. doi: 10.1200/JCO.2005.01.2179. J Clin Oncol. 2005. PMID: 16293872
-
Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy.BMC Blood Disord. 2001;1(1):2. doi: 10.1186/1471-2326-1-2. BMC Blood Disord. 2001. PMID: 11319038 Free PMC article.
-
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia.Br J Haematol. 2002 Dec;119(4):985-7. doi: 10.1046/j.1365-2141.2002.03964.x. Br J Haematol. 2002. PMID: 12472577
-
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. doi: 10.1097/00043426-200112000-00008. J Pediatr Hematol Oncol. 2001. PMID: 11902303 Review.
-
Pyomyositis during induction chemotherapy for acute lymphoblastic leukemia.J Chin Med Assoc. 2006 Apr;69(4):184-8. doi: 10.1016/S1726-4901(09)70203-5. J Chin Med Assoc. 2006. PMID: 16689202 Review.
Cited by
-
Genetic Sequence Variants in TLR4, MBL or IL-1 Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL.Children (Basel). 2020 Dec 16;7(12):296. doi: 10.3390/children7120296. Children (Basel). 2020. PMID: 33339376 Free PMC article.
-
Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients.Iran J Basic Med Sci. 2013 Sep;16(9):990-5. Iran J Basic Med Sci. 2013. PMID: 24171078 Free PMC article.
References
-
- Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol. 1997;99:580–588. doi: 10.1046/j.1365-2141.1997.4453255.x. - DOI - PubMed
-
- Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M. Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis. 1992;14:949–951. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources